Johnson & Johnson is a U.S.-based multinational healthcare company headquartered in New Brunswick, New Jersey. It operates through two primary segments: Innovative Medicine (pharmaceuticals) and MedTech (medical devices). The company discovers, develops, manufactures, and markets prescription therapeutics and medical technologies worldwide, with focus areas that include oncology, immunology, neuroscience, infectious diseases, cardiovascular and metabolism, and pulmonary hypertension. Janssen Biotech, Inc., and related Janssen entities form part of its pharmaceutical operations.
From a chemicals and manufacturing perspective, Johnson & Johnson’s pharmaceutical business spans small-molecule active pharmaceutical ingredient (API) synthesis, biologics and monoclonal antibody production, and sterile, parenteral, and solid-dose drug product manufacturing. These activities are supported by a global R&D and GMP manufacturing network, alongside extensive external partnerships and licensing arrangements. The company maintains large-scale quality, regulatory, and supply chain capabilities to supply medicines to markets worldwide.
To provide comprehensive coverage, we aggregate data and news under the name J&J, encompassing the following company names, divisions, and related entities:
Janssen Biotech, Inc..
This list encompasses current and former names, alternate names, and key divisions associated with J&J, ensuring you can easily find all relevant information under a single, unified profile.
